Brenton Flynn

Brenton Flynn

TMFNoonan

Recent articles

The Best of 2012: XOMA

Despite crashing by over 75% in 2011, XOMA is up 165% this year, putting it at #20 on our list of the very best healthcare stocks for investors in 2012.


Celldex Soars After Exciting Phase 2 Data

Celldex's new drug uses an advanced new delivery system to reach tumors, and investors are pleased; the stock is up 20% today.


Zogenix Gets the Thumbs-Down

Friday's FDA advisory committee ruling against Zogenix's painkiller Zohydro has caused shares to tank.


The Worst of 2012: MAKO Surgical

Medical robot company MAKO Surgical makes No. 10 on our list of the very worst stocks in the healthcare sector this year.


This Blockbuster Drug Gets a Green Light

A new approval for Bristol-Myers Squibb means important access to the UK market for its arthritis drug. But can the company shake a few persistent old problems?




Another Big Pharma Goes After Alzheimer's

An historically difficult area to treat, big names are competing to be the first to crack the Alzheimer's code. Here's the newest big name on that list.


The Worst of 2012: ArQule

Losing a staggering 52.8% of its share price this year, pharmaceutical company ArQule is No. 6 on our list of the very worst healthcare stocks of 2012.

The Worst of 2012: Quality Systems

The first company on our list that's down over 50% this year, with a loss of 50.8% is Quality Systems, in at #7 on our list of the very worst health care stocks of the year.


The Worst of 2012: Accretive Health

With a 48.1% loss this year, Accretive Health lands at No. 8 on our countdown of the very worst healthcare stocks of 2012.


The Worst of 2012: Delcath Systems

Delcath's drop of 47.2% puts it at No. 9 on our list of the very worst healthcare stocks of the year.



The Worst of 2012: Horizon Pharmaceuticals

As we continue the countdown of the worst stocks in healthcare for 2012, we look at No. 22 on the list, Horizon Pharmaceuticals.